Trials / Completed
CompletedNCT03182387
Key to Improve DiagNosis in Aspiration Pneumonia
Evaluation du Dosage de l'Amylase Dans le Liquide Broncho Alveolaire Dans le Diagnostic précoce de la Pneumopathie d'Inhalation Infectieuse du Sujet Comateux intubé-ventilé.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 69 (actual)
- Sponsor
- University Hospital, Bordeaux · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the diagnostic performance of amylase assay performed from bronchial alveolar fluid to differentiate aseptic chemical inhalation pneumonitis from an infectious inhalation pneumonitis in comatose patients with intubated ventilation for less than 24 hours.
Detailed description
Validation of the potential diagnostic performance of amylase assay compared to gold standard in diagnosis of infectious inhalation pneumonia of the comatose patient enabling the realization of a multicentric study using this innovative method in a diagnostic strategy with the objective of reducing the consumption of antibiotics.
Conditions
Timeline
- Start date
- 2017-08-21
- Primary completion
- 2020-11-19
- Completion
- 2020-11-19
- First posted
- 2017-06-09
- Last updated
- 2021-06-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03182387. Inclusion in this directory is not an endorsement.